Temporal trends in the prevalence, incidence, and mortality of cardiac amyloidosis in Korea over 12 years.

ABSTRACT:

Objectives

This study investigated the prevalence, incidence, and prognosis of cardiac amyloidosis (CA) in Korea.

Methods

This retrospective nationwide population-based study used the Health Insurance Review and Assessment Service databases between 2008 and 2020. All patients diagnosed with amyloidosis were included, and those with a diagnosis of heart failure or cardiomyopathy were classified as having CA. Both the special code for amyloidosis (V121), which enables coverage of medical expenses, and the corresponding International Classification of Diseases, 10th revision codes for amyloidosis (E850- E854, E858, E859) were used to improve the reliability of amyloidosis diagnosis.

Results

Among 2,239 patients with amyloidosis, 758 met the criteria for CA (mean age, 64.

SUBMITTER: Choi YJ 

PROVIDER: S-EPMC11832237 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature